Overview
Progressive muscular atrophy (PMA) is a rare motor neuron disease that primarily affects the lower motor neurons — the nerve cells in the spinal cord that control your muscles. It is sometimes considered a variant or subtype of amyotrophic lateral sclerosis (ALS), though it has distinct features. In PMA, the lower motor neurons gradually break down and die, which means the muscles they control become weak and shrink over time, a process called muscle atrophy. The disease usually begins in adulthood and tends to start in the hands, arms, or legs. Early symptoms often include muscle weakness, twitching (called fasciculations), and muscle wasting, particularly in the limbs. Unlike classic ALS, PMA does not typically show prominent signs of upper motor neuron damage early on, such as stiffness or exaggerated reflexes, though some patients may develop these signs later. The disease is progressive, meaning symptoms worsen over time. There is currently no cure for progressive muscular atrophy. Treatment focuses on managing symptoms, maintaining function, and improving quality of life. Physical therapy, occupational therapy, and assistive devices can help people stay as independent as possible. Some doctors may prescribe riluzole, a medication approved for ALS, though its benefit in PMA specifically is not firmly established. Research is ongoing to better understand PMA and develop more effective treatments.
Also known as:
Key symptoms:
Muscle weakness, especially in the arms and legsMuscle wasting or shrinking (atrophy)Muscle twitching (fasciculations)Muscle crampsDifficulty with fine hand movements like buttoning clothesWeakness in the feet leading to tripping or foot dropLoss of reflexesDifficulty lifting objectsTrouble walking or climbing stairsFatigueDifficulty swallowing in later stagesBreathing difficulties in advanced stagesWeight loss due to muscle loss
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
5 eventsFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
The University of Hong Kong — NA
Norwegian University of Science and Technology — NA
University of Maryland, Baltimore — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Progressive muscular atrophy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Progressive muscular atrophy at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Progressive muscular atrophy.
Community
No community posts yet. Be the first to share your experience with Progressive muscular atrophy.
Start the conversation →Latest news about Progressive muscular atrophy
Disease timeline:
New recruiting trial: Reproductive Prognosis in Women Seeking Offspring After Medical or Surgical Therapy for Endometriosis
A new clinical trial is recruiting patients for Progressive muscular atrophy
New recruiting trial: AngelMed Guardian® System PMA Post Approval Study
A new clinical trial is recruiting patients for Progressive muscular atrophy
New recruiting trial: Elastic Band-Progressive Resistance Training (EB-PRT) for Sarcopenia Among Heart Failure Patients
A new clinical trial is recruiting patients for Progressive muscular atrophy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Is my condition definitely PMA, or could it be ALS or another motor neuron disease?,What tests were done to rule out other conditions, and should genetic testing be considered?,How quickly is my disease likely to progress, and what signs should I watch for?,Would riluzole or any other medication be helpful in my case?,What therapies (physical, occupational, speech) should I start now?,Are there any clinical trials I might be eligible for?,When should I consider assistive devices or breathing support?
Common questions about Progressive muscular atrophy
What is Progressive muscular atrophy?
Progressive muscular atrophy (PMA) is a rare motor neuron disease that primarily affects the lower motor neurons — the nerve cells in the spinal cord that control your muscles. It is sometimes considered a variant or subtype of amyotrophic lateral sclerosis (ALS), though it has distinct features. In PMA, the lower motor neurons gradually break down and die, which means the muscles they control become weak and shrink over time, a process called muscle atrophy. The disease usually begins in adulthood and tends to start in the hands, arms, or legs. Early symptoms often include muscle weakness, t
How is Progressive muscular atrophy inherited?
Progressive muscular atrophy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Progressive muscular atrophy typically begin?
Typical onset of Progressive muscular atrophy is adult. Age of onset can vary across affected individuals.
Which specialists treat Progressive muscular atrophy?
24 specialists and care centers treating Progressive muscular atrophy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.